Grants for Public housing authorities - Health

The purpose of this Notice of Funding Opportunity (NOFO) is to solicit research designed to capacitate, transform, and scale the delivery of HIV testing, prevention, and care services through pharmacists and pharmacies in US and/or global settings. This includes theadvancement of training curricula to enable pharmacy students, pharmacists, pharmacies, and pharmacy systems to deliver the spectrum of needed HIV services with ease, equity, and effectiveness. This NOFO uses the R01 grant mechanism, while RFA-MH-25-186 uses the R21 mechanism. Projects that lack preliminary data or that propose to pilot a novel intervention may be most appropriate for the R21 mechanism. Applications with preliminary data and those proposing large-scale clinical trials or longitudinal analyses should consider using the R01 mechanism.

This funding opportunity supports innovative and high-risk neuroscience research projects that may lack extensive preliminary data, aimed at advancing our understanding of neurological and mental health disorders.

This grant provides funding to support early-career researchers from diverse backgrounds in developing independent careers focused on Alzheimer's disease and related dementias through mentored training and research opportunities.

This funding opportunity supports research using advanced laboratory models to investigate how HIV and various addictive substances interact to affect brain health and neurological disorders.

This funding opportunity supports researchers working on developing and optimizing genome editing therapies for various forms of Alzheimer's Disease-Related Dementias, aiming to advance these treatments towards clinical use.

This funding opportunity supports researchers and institutions conducting clinical trials and studies to improve stroke treatment, recovery, and prevention through collaboration within a national network.

This grant provides funding for dentists in NIH postdoctoral research positions to transition to independent research roles at academic institutions, supporting their development as new investigators.

This funding opportunity supports higher education institutions and nonprofit organizations in developing educational programs that promote diversity and encourage individuals from underrepresented backgrounds to pursue careers in biomedical and behavioral research.

The grant titled "Mechanistic and Hemodynamic Basis of Diffuse White Matter Disease in Vascular Contributions to Cognitive Impairment and Dementia (VCID)(R01 - Clinical Trial Not Allowed)" aims to fund research into the biological causes, progression, and effects of diffuse white matter disease, a common age-related brain condition linked to cognitive impairment and dementia, with the ultimate goal of reducing its impact on health.

The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), and the National Institute of Neurological Disorders and Stroke (NINDS), Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), and National Heart, Lung and Blood Institute (NHLBI), intend to publish a Notice of Funding Opportunity (NOFO) to solicit applications for Senator Paul D. Wellstone Muscular Dystrophy Specialized Research Centers (MDSRCs). These Centers promote collaborative basic, translational, and clinical research and provide important resources that can be used by the national muscular dystrophy research communities. The Centers also provide outstanding environments for the training of new researchers capable of addressing high priority objectives in muscular dystrophy research. Center investigators are expected to participate in important community outreach efforts to increase awareness of their research activities among people with lived experience and the related advocacy communities and to incorporate community perspectives into the conduct of patient-centered research. This Notice is being provided to allow potential applicants sufficient time to develop meaningful collaborations and responsive projects. The NOFO is expected to be published in Spring 2024 with an expected application due date in Summer 2024. Only New and Renewal applications will be eligible. This NOFO will utilize the P50 activity code. Details of the planned NOFO are provided below.

This grant supports licensed neurologists and neurosurgeons in the NINDS intramural program to transition to independent academic faculty positions while leading clinical trials and advancing their research careers.

This funding opportunity supports innovative projects that develop new technologies for recording and modulating brain activity, aimed at advancing research on central nervous system diseases and disorders.

This grant provides financial support for Colorado-based artists and organizations to create collaborative projects that use the arts to address pressing social, civic, environmental, and health issues in their communities.

This funding opportunity aims to establish a central hub for training and career development in kidney, urologic, and hematologic disease research, inviting a wide range of organizations to enhance collaboration and mentorship in these fields.

This grant provides funding to researchers and institutions to create expanded access programs for ALS patients who are ineligible for traditional clinical trials, allowing them to receive investigational treatments.

This funding opportunity supports a wide range of organizations in developing innovative tools to measure how psychiatric medications impact the brains of adolescents, ultimately aiming to improve treatment options for young people with mental health conditions.

This funding opportunity supports research aimed at understanding how HIV-related changes in the immune system affect the risk of tuberculosis and hepatitis B in individuals undergoing treatment, encouraging innovative approaches and collaboration among diverse research teams.

This funding opportunity supports innovative early-stage neuroscience research projects that aim to advance our understanding of neurological disorders and mental health, targeting a wide range of eligible applicants including universities, nonprofits, and small businesses.

This funding opportunity supports a wide range of organizations in optimizing and disseminating advanced biomedical technologies that have shown laboratory feasibility, enhancing their application in the biomedical research community.

This funding opportunity supports clinical trials that test new treatments for mental disorders, inviting applications from a wide range of organizations, including universities, nonprofits, and community groups, particularly those serving underrepresented populations.